Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Dickneite

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
International Journal of Immunopharmacology|January 1, 1989
Influence of the immunostimulating substance tiprotimod on Candida albicans infection in relation to activation of macrophagesG Dickneite, H U Schorlemmer, H H Sedlacek
Platelets|November 4, 2010
Reduction of r-hirudin induced bleeding in pigs by the administration of von Willebrand factorG Dickneite, H J Friesen, G Kumpe, et al.
Thrombosis and Haemostasis|July 31, 1998
Development of an anti-bleeding agent for recombinant hirudin induced skin bleeding in the pigG Dickneite, U Nicolay, H J Friesen, et al.
Behring Institute Mitteilungen|December 1, 1985
Tumor growth and metastasis increases the serum concentration of basement membrane proteinsG Dickneite, H H Sedlacek, R Timpl, et al.
Biochemical Pharmacology|July 12, 1996
First-pass elimination of a peptidomimetic thrombin inhibitor is due to carrier-mediated uptake by the liver. Interaction with bile acid transport systemsU Eckhardt, W Stüber, G Dickneite, et al.
Agents and Actions|January 1, 1993
Immunosuppressive therapy of organ-specific nephritic autoimmune diseases with 15-deoxyspergualinH U Schorlemmer, H P Neubauer, J Czech, et al.
Behring Institute Mitteilungen|April 1, 1988
15-deoxyspergualin: from cytostasis to immunosuppressionG Dickneite, H U Schorlemmer, E Weinmann, et al.
Behring Institute Mitteilungen|May 1, 1984
Immunosuppression as a desired pharmacological effectG Dickneite, R Kurrle, F R Seiler, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|August 1, 1995
Modulation of the immunoglobulin dysregulation in GvH- and SLE-like diseases by the murine IL-4 receptor (IL-4-R)H U Schorlemmer, G Dickneite, E J Kanzy, et al.
Arzneimittel-Forschung|September 1, 1989
Immunomodulation by the new synthetic thiazole derivative tiprotimod. 2nd communication: immunopharmacological activityH U Schorlemmer, G Dickneite, J Blumbach, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
International Journal of Immunopharmacology|January 1, 1989
Influence of the immunostimulating substance tiprotimod on Candida albicans infection in relation to activation of macrophagesG Dickneite, H U Schorlemmer, H H Sedlacek
Platelets|November 4, 2010
Reduction of r-hirudin induced bleeding in pigs by the administration of von Willebrand factorG Dickneite, H J Friesen, G Kumpe, et al.
Thrombosis and Haemostasis|July 31, 1998
Development of an anti-bleeding agent for recombinant hirudin induced skin bleeding in the pigG Dickneite, U Nicolay, H J Friesen, et al.
Behring Institute Mitteilungen|December 1, 1985
Tumor growth and metastasis increases the serum concentration of basement membrane proteinsG Dickneite, H H Sedlacek, R Timpl, et al.
Biochemical Pharmacology|July 12, 1996
First-pass elimination of a peptidomimetic thrombin inhibitor is due to carrier-mediated uptake by the liver. Interaction with bile acid transport systemsU Eckhardt, W Stüber, G Dickneite, et al.
Agents and Actions|January 1, 1993
Immunosuppressive therapy of organ-specific nephritic autoimmune diseases with 15-deoxyspergualinH U Schorlemmer, H P Neubauer, J Czech, et al.
Behring Institute Mitteilungen|April 1, 1988
15-deoxyspergualin: from cytostasis to immunosuppressionG Dickneite, H U Schorlemmer, E Weinmann, et al.
Behring Institute Mitteilungen|May 1, 1984
Immunosuppression as a desired pharmacological effectG Dickneite, R Kurrle, F R Seiler, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|August 1, 1995
Modulation of the immunoglobulin dysregulation in GvH- and SLE-like diseases by the murine IL-4 receptor (IL-4-R)H U Schorlemmer, G Dickneite, E J Kanzy, et al.
Arzneimittel-Forschung|September 1, 1989
Immunomodulation by the new synthetic thiazole derivative tiprotimod. 2nd communication: immunopharmacological activityH U Schorlemmer, G Dickneite, J Blumbach, et al.
Pageof 5